Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 March 2022

The Dean of the Faculty of Law invites staff and interested individuals to attend the inaugural lecture of Prof Ulrike Kistner, Department of Public Law, titled The ‘person’ in question – legally, grammatically, philosophically.

Date: 17 March 2022
Time: 17:30
Venue: Equitas Auditorium

To attend the lecture, please RSVP to Refilwe Majola at MajolaRRM@ufs.ac.za

More about the speaker:

Prof Kistner has held teaching positions in Comparative Literature at Wits University, Modern European Languages at UNISA, and Philosophy at the University of Pretoria. She is currently working at intersections between political philosophy, social theory, jurisprudence, and psychoanalytic theory.

Abstract:

A major shift has been noted in constitutionalism and human rights frameworks – from human and civil rights to principles centred on ‘personhood’ and ‘dignity’. This shift calls for closer historical-critical investigation of the status of ‘person’. Roberto Esposito directs this inquiry to a philosophical grammar of the impersonal third person.

My contribution to this inquiry sets in with a probing of Esposito’s propositions, considering the post-apartheid elevation of ‘person’ in constitutionalism and philosophical elaborations of communitarianism. To the extent that the concept of ‘ubuntu’ is embedded in a linguistic ontology developed by Kinyarwanda, my argument will navigate between Rwanda and South Africa in the mid-1990s, and between juridical, moral-philosophical, linguistic, and Africanist notions of ‘ubuntu’ and corresponding claims on African philosophy.

The radical questioning of ethnolinguistic tenets on the part of some African philosophers brings me back to the philosophical grammar of the third person which, far from being confined to study old grammar books, opens alternatives to ethnophilosophical approaches to the ‘person’ in question. 

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept